DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $38.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$38.3M
Enterprise Value
$10.5M
PV of Cash Flows
$27.8M
PV of Terminal Value
$44.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $31.0M | $4.5M | 15.0% | $2.3M | $2.1M |
| Year 2 | $31.9M | $5.0M | 16.0% | $2.6M | $2.1M |
| Year 3 | $32.9M | $5.4M | 17.0% | $2.9M | $2.2M |
| Year 4 | $33.8M | $5.8M | 17.0% | $3.1M | $2.1M |
| Year 5 | $34.9M | $6.0M | 17.0% | $3.3M | $2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $38.3M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$30.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1408926606031599
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5